Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2012 / Cilt: 38 - Sayı: 1

Erektil disfonksiyonda hormonal değerlendirme

Hormonal evaluation in erectile dysfunction

Pages
19–22
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When appropriate, hormone levels should be measured and treated in patients who present with ED.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Erectile dysfunction (ED) is defined as the inability to achieve and maintain an erection suffi - cient to permit satisfactory sexual intercourse.
📊
Key Findings & Data:Material and methods: We evaluated 178 patients between the ages of 25 and 85 years old.
💡
Conclusion & Impact:When appropriate, hormone levels should be measured and treated in patients who present with ED.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Erectile dysfunction (ED) is defined as the inability to achieve and maintain an erection suffi - cient to permit satisfactory sexual intercourse. In this study, we evaluated the relationship between ED and hormonal abnormalities. Material and methods: We evaluated 178 patients between the ages of 25 and 85 years old. Medical his - tories and details were collected, and the IIEF question test was completed by all patients. After the basic evaluation, serum total testosterone, thyroid stimulating hormone (TSH), prolactin, follicle stimulating hor - mone (FSH) and luteinizing hormone (LH) levels were measured. Results: The mean age of the patients and IIEF scores were 50.5±12.3 and 12.8±6.13, respectively. The mean testosterone, prolactin, TSH, LH and FSH were 426±152 ng/dL, 15.8±45.6 ng/mL, 1.56±1.2 micro IU/mL, 5.5±4.3 m IU/mL and 7.7±6.9 m IU/mL, respectively. Two patients had abnormal TSH levels, and 27 patients had abnormal LH levels. Abnormal FSH levels were detected in 6 patients. Eight patients had abnormal testosterone levels, and twenty had abnormal prolactin levels. Conclusion: ED is an illness that affects older men, and multiple factors cause this illness. Hormonal abnormalities are one of these factors that can be corrected. When appropriate, hormone levels should be measured and treated in patients who present with ED.

Özet

Amaç: Erektil disfonksiyon (ED) cinsel ilişki için gerekli olan penil ereksiyonun başlatılmasında, sağlan - masında ve devamında yetersizlik olarak tanımlanmaktadır. Çalışmamızda ED ile hormonal anormallik arasındaki ilişkiyi değerlendirdik. Gereç ve yöntem: Erektil disfonksiyon ile polikliniğimize başvuran ve yaşları 25 ile 85 arasında değişen 178 erkek hasta çalışmaya alındı. Tüm hastalardan ayrıntılı anamnez alındı ve International Index of Erecti - le Function (IIEF) sorgulama formu dolturtuldu. Temel değerlendirmeler sonrasında hastaların serum total testosteron, TSH, prolaktin ve LH düzeyleri ölçüldü. Bulgular: Çalışmaya alınan 178 hastanın yaş ortalaması 50.5±12.3 idi. Ortalama IIEF skoru 12.8±6.13 olarak tespit edildi. Testosteron 426±152, prolaktin 15.8±45.6, TSH 1.56±1.2, LH 5.5±4.3 ve FSH 7.7±6.9 olarak tespit edildi. İki olguda (%1.1) TSH, 27 olguda (%15.2) LH, 6 olguda (%3.4) FSH, 8 olguda (%4.5) testosteron ve 20 olguda (%11.2) prolaktin düzeyleri anormal olarak tespit edildi. Sonuç: ED, ileri yaşlarda görülme sıklığı artan bir hastalıktır ve etyolojisinde birçok faktör rol almaktadır. Bu faktörlerden biri hormonal anormalliklerdir ve tedavi edilebilir bir durumdur. ED şikayeti ile başvuran hastalarda bu durum araştırılmalı ve gereğinde tedavi edilmelidir.

🔖

Cite This Article

ÇALIŞKAN, S., KOCA, O., ÖZTÜRK, M., AKYÜZ, M., KARAMAN, M. İ. (2012). Erektil disfonksiyonda hormonal değerlendirme. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 38 - Sayı: 1, 19–22. https://ajindex.com/articles/328899

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urology 2010
  2. [CrossRef] 2.Beckman TJ, Abu-Lebdeh HS, Mynderse LA. Evaluation and medical management of erectile dysfunction. Mayo Clin Proc 2006
  3. [CrossRef] 3.Tunç L, Küpeli B, Tuncel A, Biri H, Kordan Y, Deniz N, et al. Erektil Disfonksiyon Kardiyovasküler Hastalığın Erken Habercisi Olabilir mi? Fırat Tıp Dergisi 2007
  4. Aversa A, Isidori AM, Greco EA, Giannetta E, Gianfrilli D, Spera E, et al. Hormonal supplementation and erectile dysfunction. Eur Urology 2004
  5. [CrossRef] 5.Aversa A, Isidori AM, De Martino MU, Caprio M, Fabbrini E, Rocchietti-March M, et al. Androjens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol (Oxf) 2000
  6. [CrossRef] 6.Raijfer J. Relationship between testosterone and erectile dysfunction. Rev Urol 2000
  7. Lue TF. Physiology of Penile Erection and Pathophysiology of Erectile Dysfunction. In: Kavoussi LR, Novick AC, Partin AW, Peters CA, Wein AJ, eds Campell-Walsh Urology Nineth Edition Philadelphia: W.B Saunders
  8. 2007, s 740. 8.Bella AJ, Lue TF. Erkeklerde Cinsel İşlev Bozukluğu In Smith GENEL Üroloji 17. Türkçe Baskı İstanbul: Nobel Tıp Kitabevleri 2004, s 594. 9.Akkuş E, Kadıoğlu A, Esen A, Doran S, Ergen A, Anafarta K, et al. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urology 2002
  9. [CrossRef] 10.Rhoden EL, Teloken C, Sogari PR, Souto CA. The relationship of serum testosterone to erectile function in normal aging men. J Urol 2002
  10. [CrossRef] 11.Low WY, Khoo EM, Tan HM, Hew FL, Teoh SH. Depression, hormonal status and erectile dysfunction in the aging male: results from a community study in Malaysia. J Men’s Health&Gender 2006
  11. [CrossRef] 12.Guay AT, Perez JB, Jacobson J, Newton RA. Efficacy and safety of sildenafil for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 2001
  12. Forest C, Caretta N, Rossato M, Garolla A, Ferlin A. Role of androgens in erectile function. J Urology 2004
  13. [CrossRef] 14.Carani C, Granata AR, Bancroft J, Marrama P. The effects of testosterone replacement on nocturnal penile tumescence and rigidity and erectile response t